Oxfendazole Development Group
PeerBasis did not identify a benchmark-executive compensation figure for Oxfendazole Development Group in its current latest-filed snapshot; this does not mean the organization reported no executive compensation.
Review the available peer set
Peer data are available for Oxfendazole Development Group. Open the preview and enter the 2025-dollar compensation amount the board is evaluating before preparing a report.
Open the previewSelected peer organizations
Actual selection tier: Same NTEE major group (H), nationwide + size band 0.67–1.5× expenses. Displayed D + F figures from supported filing years are indexed to 2025 comparison dollars with BLS CPI-U; a nationwide tier also uses 2024 BEA RPP as a consumer price-level proxy when both the subject and peer have supported state codes. Unsupported state codes receive no interstate adjustment. Comparison values can differ from the raw filing. Column F may include related-organization amounts.
| Organization | State | Revenue | D + F (2025 dollars) |
|---|---|---|---|
| Community Rebuilds | UT | $759,721 | $96,705 |
| Premier Community Health | OH | $809,250 | $62,336 |
| Biostasis Technologies Inc | FL | $868,209 | $114,627 |
| International Society For Urban Health | NY | $924,090 | $160,835 |
| Hoffman Institute Supporting Foundation | CA | $4,191,180 | $25,210 |
| Targetcancer Foundation Inc | MA | $1,261,609 | $160,567 |
| Whole Systems Healthcare | OR | $884,913 | $27,545 |
| Middle Tennessee Research Institute | TN | $527,680 | $97,865 |
View the organization record and available filings on ProPublica